RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Regardless of how one maneuvers the number of shares out, they need to achieve something tangible--data and/or deals--to raise the overall value of the company enough that a financing would be nontoxic. I can imagine a point where a reverse split might make sense in terms of an AMEX or NASDAQ listing--but otherwise it's irrelevant right now. The value of the company needs to be enhanced in order to raise money at anything approaching a reasonable cost. And a reverse split does nothing to alter the fundamental value of the company.

NeuroInvestment